Plasma exosome-derived fragile site-associated tumor suppressor as a powerful prognostic predictor for patients with ovarian cancer

The objective of the study was to investigate the levels of plasma exosome-derived fragile site-associated tumor suppressor (FATS) and evaluate its prognostic predictive ability in ovarian cancer (OC) patients. Exosome-rich fractions were isolated from the plasma of 90 patients with OC enrolled in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Renjing, Chen, Xiaochun, Zhang, Shiliang, Liu, Bin, Pei, Hao, Tu, Fan, Liu, Jun, Yu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162747/
https://www.ncbi.nlm.nih.gov/pubmed/34491890
http://dx.doi.org/10.17305/bjbms.2021.6404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162747/
https://www.ncbi.nlm.nih.gov/pubmed/34491890
http://dx.doi.org/10.17305/bjbms.2021.6404

Ejemplares similares